Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open Label, Multicenter, Allopurinol- Controlled Study to Assess the Safety and Efficacy of Oral Febuxostat in Patients With Gout

NCT01736514 is registered in ClinicalTrials.gov with Astellas Pharma Taiwan, Inc. as lead sponsor.

NCT NCT01736514
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01736514 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open Label, Multicenter, Allopurinol- Controlled Study to Assess the Safety and Efficacy of Oral Febuxostat in Patients With Gout
Lead sponsor
Astellas Pharma Taiwan, Inc.
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2011
Completion date
February 29, 2012
Enrollment
109 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

gout